Related Experiment Video
Updated: Jun 14, 2026

13:25
Transient Transduction of the Strobilated Forms of Echinococcus granulosus
Published on: September 16, 2022
[Complex therapy of echinococcosis in children]
Khirurgiia
|March 26, 2010
Summary
The immune-enzyme assay (IEA) shows high accuracy for detecting liver echinococcosis recurrence. This study also highlights the success of conservative treatments and preventive chemotherapy in managing echinococcosis in children.
Area of Science:
- Medical Parasitology
- Immunodiagnostics
- Pediatric Surgery
Background:
- Echinococcosis poses a significant health challenge, particularly in children, affecting organs like the liver and lungs.
- Accurate diagnostic methods are crucial for effective management and monitoring of echinococcosis.
- Postoperative surveillance is essential to detect disease recurrence promptly.
Purpose of the Study:
- To analyze the efficacy of the immune-enzyme assay (IEA) for diagnosing liver and lung echinococcosis in children.
- To evaluate the reliability of IEA in detecting disease recurrence after surgical intervention.
- To assess the outcomes of conservative treatment strategies, including antiparasitic and preventive chemotherapy.
Main Methods:
- Retrospective analysis of immune-enzyme assay (IEA) results in pediatric patients with liver and lung echinococcosis.
- Evaluation of IEA accuracy and sensitivity for hepatic and pulmonary forms of the disease.
- Review of cases treated with conservative management (antiparasitic therapy, auxiliary therapy, preventive chemotherapy) and their follow-up outcomes.
Main Results:
- IEA demonstrated high accuracy (91%) and sensitivity (86%) for liver echinococcosis.
- IEA showed moderate accuracy (57%) and sensitivity (55%) for lung echinococcosis.
- Conservative treatment was successfully applied to pediatric patients, with no recurrences observed during a 5-year follow-up period.
Conclusions:
- IEA is a reliable method for diagnosing liver echinococcosis and detecting recurrence postoperatively in children.
- Conservative management, including preventive chemotherapy, is effective in managing pediatric echinococcosis and preventing recurrence.
- Further research may be warranted to improve IEA performance for lung echinococcosis.
Related Concept Videos
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
